Comments due: 
11 Nov 2019

In the U.S. alone, over 1.5 million people live with Type 1 Diabetes (T1D); approximately 30,000 people are diagnosed every year.  

With support from The Leona M. and Harry B. Helmsley Charitable Trust, CDISC is developing new T1D CDISC standards that will extend published diabetes standards by developing machine-readable metadata in the following focus areas: Pediatrics, Devices, Prevention, and Exercise. These standards will make it easier for all stakeholders (clinicians, researchers, drug development companies, and regulatory authorities) to  share and compare data to foster innovation and to evaluate the effectiveness of emerging T1D treatments.

We invite you to provide comments on TAUG-T1D during the open Public Review period. Public review is a key quality step in our Standards Development Process.

View the draft: TAUG-T1D. The public review closes 11 November 2019.

We have held several webinars throughout the development process. Please visit our T1D page to listen.

CDISC relies on your input to ensure neutral, consensus-based standards are developed and adopted by a diverse global community interested in improving clinical research.

You will need to log in or register for the CDISC Wiki to provide comments.  

CDISC Wiki is a different login from